A CONVENIENT PREFILLED, NO-MIX SYRINGE FOR GnRH AGONIST TREATMENT OF ADVANCED PROSTATE CANCER IN ADULTS
CAMCEVI® is the first sub-Q leuprolide that comes prefilled with no mixing. In an open-label, single-arm study of 137 adults who received 42 mg of CAMCEVI on Day 0 and Week 24, CAMCEVI offered consistent testosterone suppression to castrate levels, after the initial injection, from Week 4 to Week 48.1
See how simple syringe prep can be
PROVEN
LEUPROLIDE EFFICACY
CAMCEVI offers proven leuprolide efficacy in a convenient prefilled,
no-mix syringe.1


SIMPLIFIED
PREPARATION
CAMCEVI comes prefilled with no mixing required—simplifying syringe prep for you.1
Learn more about dosingADDITIONAL RESOURCES
AND SUPPORT
Access useful resources, information, and more for you and your patients.
See all resources